
Zymeworks Inc
ZYMEHealthcare|Biotechnology|USA
$25.88
-1.19 (-4.40%)
Tangible Book
$2.04
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (77)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Galbraith Kenneth | Chair & CEO | 2026-01-12 | SELL | 30,424 | $22.67 | $689.7K |
| Smith Jeffrey T L | EVP & Chief Medical Officer | 2026-01-12 | SELL | 9,310 | $22.67 | $211.1K |
| Hollywood Mark | EVP & COO | 2026-01-12 | SELL | 6,120 | $22.67 | $138.7K |
| Moore Paul Andrew | Chief Scientific Officer | 2026-01-12 | SELL | 9,560 | $22.67 | $216.7K |
| Smith Jeffrey T L | EVP & Chief Medical Officer | 2026-01-05 | SELL | 10,538 | $25.1 | $264.5K |
| Galbraith Kenneth | Chair & CEO | 2026-01-05 | SELL | 54,343 | $25.1 | $1364K |
| Moore Paul Andrew | Chief Scientific Officer | 2026-01-05 | SELL | 20,110 | $25.1 | $504.8K |
| Galbraith Kenneth | Chair & CEO | 2025-12-22 | SELL | 47,528 | $27.02 | $1284.2K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-05-19 | BUY | 55,421 | $11.47 | $635.7K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-04-17 | BUY | 128,713 | $11.32 | $1457K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-04-04 | BUY | 317,208 | $11.42 | $3622.5K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-04-02 | BUY | 127,415 | $11.75 | $1497.1K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-03-26 | BUY | 97,349 | $12.61 | $1227.6K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-03-24 | BUY | 127,198 | $12.92 | $1643.4K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-03-19 | BUY | 228,463 | $12.55 | $2867.2K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-03-13 | BUY | 1,081,980 | $12.13 | $13124.4K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-01-17 | BUY | 141,429 | $13.88 | $1963K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-01-15 | BUY | 167,654 | $13.59 | $2278.4K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-01-10 | BUY | 225,119 | $13.21 | $2973.8K |
| Moore Paul Andrew | Chief Scientific Officer | 2025-01-06 | SELL | 21,200 | $14.92 | $316.3K |
| Galbraith Kenneth | Chair & CEO | 2025-01-06 | SELL | 57,291 | $14.92 | $854.8K |
| Smith Jeffrey T L | EVP & Chief Medical Officer | 2025-01-06 | SELL | 11,110 | $14.92 | $165.8K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2025-01-02 | BUY | 363,369 | $14.64 | $5319.7K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2024-12-27 | BUY | 130,309 | $14.44 | $1881.7K |
| EcoR1 Capital, LLC | Director, 10% Owner | 2024-12-23 | BUY | 1,254,808 | $13.98 | $17542.2K |
| Moore Paul Andrew | Chief Scientific Officer | 2024-01-08 | SELL | 9,799 | $10.79 | $105.7K |
| Galbraith Kenneth | Chair & CEO | 2024-01-08 | SELL | 23,904 | $10.79 | $257.9K |
| Astle Christopher | SVP & CFO | 2024-01-08 | SELL | 5,994 | $10.79 | $64.7K |
| Astle Christopher | SVP & CFO | 2023-12-11 | SELL | 886 | $9.13 | $8.1K |
| EcoR1 Capital, LLC | 10% Owner | 2023-06-16 | BUY | 3,350,000 | $8.12 | $27202K |
| EcoR1 Capital, LLC | 10% Owner | 2023-03-28 | BUY | 200,000 | $8 | $1600K |
| Klompas Neil A | President & COO | 2023-03-10 | SELL | 2,977 | $7.83 | $23.3K |
| EcoR1 Capital, LLC | 10% Owner | 2023-01-20 | BUY | 307,500 | $9.7 | $2982.8K |
| EcoR1 Capital, LLC | 10% Owner | 2023-01-18 | BUY | 985,100 | $9.84 | $9693.4K |
| EcoR1 Capital, LLC | 10% Owner | 2023-01-11 | BUY | 1,026,300 | $7.67 | $7871.7K |
| Astle Christopher | SVP & CFO | 2022-12-12 | SELL | 887 | $6.01 | $5.3K |
| Astle Christopher | SVP & CFO | 2022-12-12 | SELL | 887 | $6.01 | $5.3K |
| Josephson Neil | Chief Medical Officer | 2022-11-10 | SELL | 2,475 | $8.1 | $20K |
| Josephson Neil | Chief Medical Officer | 2022-11-10 | SELL | 2,475 | $8.1 | $20K |
| Josephson Neil | Chief Medical Officer | 2022-11-10 | SELL | 2,475 | $8.1 | $20K |
| Redmile Group, LLC | 10% Owner | 2022-10-13 | BUY | 30,481 | $5.03 | $153.3K |
| Klompas Neil A | COO | 2022-03-10 | SELL | 2,979 | $6.88 | $20.5K |
| Josephson Neil | Chief Medical Officer | 2022-01-07 | BUY | 5,000 | $14.28 | $71.4K |
| Tehrani Ali | CEO | 2021-07-16 | SELL | 44,991 | $36 | $1619.7K |
| Tehrani Ali | CEO | 2021-07-12 | SELL | 12,669 | $36.12 | $457.6K |
| Priour James | Chief Commercial Officer | 2021-04-13 | SELL | 950 | $27.93 | $26.5K |
| O'Driscoll Kathryn | Chief People Officer | 2021-03-15 | SELL | 786 | $34.72 | $27.3K |
| O'Driscoll Kathryn | Chief People Officer | 2021-03-10 | SELL | 568 | $34.95 | $19.9K |
| Polverino Anthony J. | Chief Scientific Officer | 2021-03-10 | SELL | 1,048 | $34.95 | $36.6K |
| Tehrani Ali | CEO | 2021-03-10 | SELL | 4,392 | $34.95 | $153.5K |
| HAUSMAN DIANA | Chief Medical Officer | 2021-03-10 | SELL | 1,048 | $34.95 | $36.6K |
| Klompas Neil A | CFO | 2021-03-10 | SELL | 1,425 | $34.95 | $49.8K |
| Klompas Neil A | CFO | 2020-12-09 | SELL | 25,000 | $53.25 | $1331.3K |
| Klompas Neil A | CFO | 2020-12-09 | SELL | 25,000 | $53.25 | $1331.3K |
| Tehrani Ali | CEO | 2020-12-07 | SELL | 850 | $56.16 | $47.7K |
| HAUSMAN DIANA | Chief Medical Officer | 2020-12-04 | SELL | 6,032 | $55.12 | $332.5K |
| HAUSMAN DIANA | Chief Medical Officer | 2020-12-02 | SELL | 18,968 | $55.19 | $1046.8K |
| Tehrani Ali | CEO | 2020-11-02 | SELL | 3,500 | $39.04 | $136.6K |
| HAUSMAN DIANA | Chief Medical Officer | 2020-09-14 | SELL | 40,000 | $45 | $1800K |
| Tehrani Ali | CEO | 2020-04-03 | BUY | 575 | $33.39 | $19.2K |
| Cox Troy | Director | 2020-01-27 | BUY | 7,500 | $46.5 | $348.8K |
| Poon David Kai Yuen | See Remarks | 2019-05-06 | SELL | 800 | $19.2 | $15.4K |
| Klompas Neil A | CFO | 2019-05-06 | SELL | 8,308 | $19.23 | $159.8K |
| Tehrani Ali | CEO | 2019-03-29 | SELL | 3,000 | $16.24 | $48.7K |
| LILLY ELI & CO | 10% Owner | 2019-01-31 | SELL | 250,000 | $16 | $4000K |
| LILLY ELI & CO | 10% Owner | 2018-11-06 | SELL | 700,000 | $14 | $9800K |
| LILLY ELI & CO | 10% Owner | 2018-09-24 | SELL | 2,027 | $16.36 | $33.2K |
| LILLY ELI & CO | 10% Owner | 2018-09-18 | SELL | 6,870 | $14.56 | $100K |
| LILLY ELI & CO | 10% Owner | 2018-09-17 | SELL | 15,874 | $14.58 | $231.4K |
| LILLY ELI & CO | 10% Owner | 2018-09-13 | SELL | 30,959 | $14.49 | $448.6K |
| LILLY ELI & CO | 10% Owner | 2018-09-11 | SELL | 15,777 | $14.75 | $232.7K |
| LILLY ELI & CO | 10% Owner | 2018-08-31 | SELL | 700 | $14.26 | $10K |
| LILLY ELI & CO | 10% Owner | 2018-08-30 | SELL | 5,752 | $14.31 | $82.3K |
| LILLY ELI & CO | 10% Owner | 2018-08-14 | SELL | 3,000 | $14.28 | $42.8K |
| LILLY ELI & CO | 10% Owner | 2018-08-13 | SELL | 6,429 | $14.32 | $92.1K |
| LILLY ELI & CO | 10% Owner | 2018-08-03 | SELL | 1,650 | $13.55 | $22.4K |
| LILLY ELI & CO | 10% Owner | 2018-08-02 | SELL | 19,400 | $13.31 | $258.2K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked